NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Brevel

Brevel

Private
IsraelHealthcare & Life Scienceshttps://brevel.co.il/

Last Round

Grant

Jun 23, 2026

Total Funding Raised

$69.56M

Company Overview

Brevel is a biotechnology company that develops an illuminated fermentation platform to produce sustainable, high-quality microalgae protein for the food, nutrition, and pharmaceutical industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Sustainable Materials, Clean Manufacturing

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Non-AI

Keywords

microalgae proteinfermentation platformplant-based proteinalt-proteinilluminated fermentationfood technatural food colorantbiomanufacturingplant cell cultureprecision fermentationsustainable ingredientsbiotech ingredientsCPG ingredientsnovel foodsB2B food supply

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Brevel Comps

Public and private peers based on sector, stage, and business model.

Brevel comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Brevel Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 23, 2026
SeedMar 24, 2025
SeedJul 25, 2023
SeedJun 1, 2023
GrantApr 1, 2018

Key People

Founding team and executive leadership

Ido Golan

Co-Founder And CTO

Founding Team

Yonatan Golan

CEO

Executive Team

Amitai Hirshman

Chief Financial Officer

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 3, 2026

    Launched Purallis, a clean-label chlorella for the supplement sector.

  • Mar 24, 2025

    $25M raised in Seed round.

Brevel Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Brevel Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Brevel's valuation, stock price, and market status.

Firmographic Details

HeadquartersIsrael
Employee Range34
Year Founded2017
Last FundingJun 23, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.